Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
0013, 0025, 0069, 60793, 72618
Strengths (from the 100 most recently listed products)
Doxorubicin hydrochloride 2 mg/mL; Human immunoglobulin g 100 mg/mL; Human immunoglobulin g 165 mg/mL; Human immunoglobulin g 50 mg/mL; Amlodipine besylate 5 mg/1; Amlodipine besylate 10 mg/1; Propofol 10 mg/mL; Marstacimab 150 mg/mL; Talazoparib tosylate .5 mg/1; Atorvastatin calcium trihydrate 80 mg/1; Atorvastatin calcium trihydrate 20 mg/1; Atorvastatin calcium trihydrate 40 mg/1; Atorvastatin calcium trihydrate 10 mg/1; Rimegepant sulfate 75 mg/1; Thrombin 5000 [iU]/5mL; Bnt-162b2 omicron (Xfg) mrna .0158 mg/.48mL; Bnt-162b2 omicron (Xfg) mrna .042 mg/.418mL; Marstacimab 75 mg/.5mL; Thrombin 20000 [iU]/20mL; Leucovorin calcium 5 mg/1
Dosage forms
Injection, Solution, Solution, Tablet, Film coated, Kit, Capsule, Liquid filled, Injection, Suspension, Capsule, Capsule, Coated pellets, Injection, Injection, Emulsion, Liquid, Injection, Powder, Lyophilized, For solution, Tablet, Orally disintegrating, Tablet, System, Spray, Tablet, Film coated, Extended release
Routes
Oral, Intravenous, Subcutaneous, Intramuscular, Topical, Vaginal, Nasal
Drug classes (FDA established)
Human Immunoglobulin G, Anthracycline Topoisomerase Inhibitor, Kinase Inhibitor, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, HMG-CoA Reductase Inhibitor, Poly(ADP-Ribose) Polymerase Inhibitor, Janus Kinase Inhibitor, Calcitonin Gene-related Peptide Receptor Antagonist, General Anesthetic, Blood Coagulation Factor, Recombinant Human Growth Hormone, Erythropoiesis-stimulating Agent, CD20-directed Cytolytic Antibody, Vascular Endothelial Growth Factor Inhibitor, Folate Analog, Sphingosine 1-phosphate Receptor Modulator, Estrogen, Anti-coagulant, Low Molecular Weight Heparin, HER2/neu Receptor Antagonist, Leukocyte Growth Factor
Package NDCs
108 (from the 100 most recently listed products)

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Pfizer Laboratories Div Pfizer Inc NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
Panzygaimmune globulin intravenous (human)Human immunoglobulin g 100 mg/mLSolutionIntravenous0069-101100069-1011-02—
Panzygaimmune globulin intravenous (human)Human immunoglobulin g 100 mg/mLSolutionIntravenous0069-122400069-1224-02—
Panzygaimmune globulin intravenous (human)Human immunoglobulin g 100 mg/mLSolutionIntravenous0069-131200069-1312-02—
Panzygaimmune globulin intravenous (human)Human immunoglobulin g 100 mg/mLSolutionIntravenous0069-110900069-1109-02—
Panzygaimmune globulin intravenous (human)Human immunoglobulin g 100 mg/mLSolutionIntravenous0069-155800069-1558-02—
Zithromaxazithromycin dihydrateAzithromycin dihydrate 250 mg/1Tablet, Film coatedOral0069-406100069-4061-01—
Vyndaqeltafamidis meglumineTafamidis meglumine 20 mg/1Capsule, Liquid filledOral0069-197500069-1975-40—
Nivestymfilgrastim-aafiFilgrastim 300 ug/mLInjection, SolutionIntravenous, Subcutaneous0069-029300069-0293-10—
Nivestymfilgrastim-aafiFilgrastim 480 ug/1.6mLInjection, SolutionIntravenous, Subcutaneous0069-029400069-0294-10—
DaurismoglasdegibGlasdegib 100 mg/1Tablet, Film coatedOral0069-153100069-1531-30—
DaurismoglasdegibGlasdegib 25 mg/1Tablet, Film coatedOral0069-029800069-0298-60—
LorbrenalorlatinibLorlatinib 100 mg/1Tablet, Film coatedOral0069-023100069-0231-01—
LorbrenalorlatinibLorlatinib 25 mg/1Tablet, Film coatedOral0069-022700069-0227-0100069-0227-03—
TalzennatalazoparibTalazoparib tosylate .25 mg/1CapsuleOral0069-029600069-0296-30—
TalzennatalazoparibTalazoparib tosylate 1 mg/1CapsuleOral0069-119500069-1195-30—
VizimprodacomitinibDacomitinib 30 mg/1Tablet, Film coatedOral0069-119800069-1198-30—
VizimprodacomitinibDacomitinib 45 mg/1Tablet, Film coatedOral0069-229900069-2299-30—
VizimprodacomitinibDacomitinib 15 mg/1Tablet, Film coatedOral0069-019700069-0197-30—
Nivestymfilgrastim-aafiFilgrastim 300 ug/.5mLInjection, SolutionSubcutaneous0069-029100069-0291-0100069-0291-10—
Nivestymfilgrastim-aafiFilgrastim 480 ug/.8mLInjection, SolutionSubcutaneous0069-029200069-0292-0100069-0292-10—
XeljanztofacitinibTofacitinib citrate 10 mg/1Tablet, Film coatedOral0069-100200069-1002-01—
Retacritepoetin alfa-epbxEpoetin 10000 [iU]/mLInjection, SolutionIntravenous, Subcutaneous0069-130800069-1308-10—
Retacritepoetin alfa-epbxEpoetin 3000 [iU]/mLInjection, SolutionIntravenous, Subcutaneous0069-130600069-1306-10—
Retacritepoetin alfa-epbxEpoetin 40000 [iU]/mLInjection, SolutionIntravenous, Subcutaneous0069-130900069-1309-04—
Retacritepoetin alfa-epbxEpoetin 4000 [iU]/mLInjection, SolutionIntravenous, Subcutaneous0069-130700069-1307-10—
Retacritepoetin alfa-epbxEpoetin 2000 [iU]/mLInjection, SolutionIntravenous, Subcutaneous0069-130500069-1305-10—
BosulifbosutinibBosutinib monohydrate 400 mg/1Tablet, Film coatedOral0069-019300069-0193-01—
EucrisacrisaboroleCrisaborole 20 mg/gOintmentTopical55724-21155724-0211-1155724-0211-2155724-0211-23+1 more—
Inflectrainfliximab-dyybInfliximab 100 mg/10mLInjection, Powder, Lyophilized, For solutionIntravenous0069-080900069-0809-01J1745
Xeljanz XRtofacitinibTofacitinib citrate 11 mg/1Tablet, Film coated, Extended releaseOral0069-050100069-0501-30—
Fragmindalteparin sodiumDalteparin sodium 2500 [iU]/.2mLInjectionSubcutaneous0069-019500069-0195-02—
Fragmindalteparin sodiumDalteparin sodium 15000 [iU]/.6mLInjectionSubcutaneous0069-022300069-0223-02—
Fragmindalteparin sodiumDalteparin sodium 10000 [iU]/mLInjectionSubcutaneous0069-021700069-0217-02—
Fragmindalteparin sodiumDalteparin sodium 7500 [iU]/.3mLInjectionSubcutaneous0069-020600069-0206-02—
Fragmindalteparin sodiumDalteparin sodium 5000 [iU]/.2mLInjectionSubcutaneous0069-019600069-0196-02—
Fragmindalteparin sodiumDalteparin sodium 12500 [iU]/.5mLInjectionSubcutaneous0069-022000069-0220-02—
Fragmindalteparin sodiumDalteparin sodium 25000 [iU]/mLInjectionSubcutaneous0069-023200069-0232-01—
Fragmindalteparin sodiumDalteparin sodium 18000 [iU]/.72mLInjectionSubcutaneous0069-022800069-0228-02—
IbrancepalbociclibPalbociclib 125 mg/1CapsuleOral0069-018900069-0189-21—
IbrancepalbociclibPalbociclib 75 mg/1CapsuleOral0069-018700069-0187-21—
IbrancepalbociclibPalbociclib 100 mg/1CapsuleOral0069-018800069-0188-21—
Sutentsunitinib malateSunitinib malate 37.5 mg/1CapsuleOral0069-083000069-0830-38—
Zithromaxazithromycin dihydrateAzithromycin dihydrate 500 mg/5mLInjection, Powder, Lyophilized, For solutionIntravenous0069-040000069-0400-10—
Cerebyxfosphenytoin sodiumFosphenytoin sodium 50 mg/mLInjection, SolutionIntramuscular, Intravenous0069-547100069-5471-02—
Cerebyxfosphenytoin sodiumFosphenytoin sodium 50 mg/mLInjection, SolutionIntramuscular, Intravenous0069-600100069-6001-2100069-6001-25—
Cerebyxfosphenytoin sodiumFosphenytoin sodium 50 mg/mLInjection, SolutionIntramuscular, Intravenous0069-547400069-5474-02—
XeljanztofacitinibTofacitinib citrate 5 mg/1Tablet, Film coatedOral0069-100100069-1001-01—
BosulifbosutinibBosutinib monohydrate 500 mg/1Tablet, Film coatedOral0069-013600069-0136-01—
BosulifbosutinibBosutinib monohydrate 100 mg/1Tablet, Film coatedOral0069-013500069-0135-01—
Elelysotaliglucerase alfaTaliglucerase alfa 200 U/5mLInjection, Powder, Lyophilized, For solutionIntravenous0069-010600069-0106-01—

Pfizer Laboratories Div Pfizer Inc: common questions

What is Pfizer Laboratories Div Pfizer Inc's NDC labeler code?
0013, 0025, 0069, 60793, 72618. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for Pfizer Laboratories Div Pfizer Inc?
Med-Code's HCPCS directory matches CPT 90678, J9355, J2506, J9312, J9035 to these products. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Pfizer Laboratories Div Pfizer Inc NDC Codes | Med-Code